Tirzepatide is different because it addresses multiple problems at once: It increases insulin when needed but not when its not needed, which reduces the risk of low blood sugar (hypoglycemia)
While these research developments underscore the potential of GLP-1s treating diseases beyond diabetes and obesity, the emergence of new indications is not without its challenges -- particularly issues stemming from GLP-1 medication shortages, high costs, and potential hurdles in providing coverage
While DHA and melanotan remain the dominant agents in current use, forskolin and carotenoids offer alternative pathways for pigmentation and photoprotection
Can Semaglutide Cause Leg Cramps
Start a fiber supplement before or at the same time you begin GLP-1 medication, not after constipation develops
For comparison with tirzepatide, read semaglutide vs tirzepatide